These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2179793)

  • 41. Twenty two weeks of transdermal estradiol increases sex hormone-binding globulin in surgical menopausal women.
    Başbuğ M; Aygen E; Tayyar M; Muhtaroğlu S; Demir I; Okten S
    Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):149-52. PubMed ID: 9228496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of hormone replacement therapy during menopause in the cardiovascular prevention].
    Turpin G
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):177-80. PubMed ID: 8024230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Migraine, hormones and the menopausal transition.
    Hipolito Rodrigues MA; Maitrot-Mantelet L; Plu-Bureau G; Gompel A
    Climacteric; 2018 Jun; 21(3):256-266. PubMed ID: 29521155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].
    Valéra MC; Chantalat E; Vinel A; Benoit T; Guillaume M; Game X; Gourdy P; Trémollières F; Payrastre B; Arnal JF
    Presse Med; 2015; 44(7-8):805-11. PubMed ID: 26278157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy.
    Gordon SF
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):998-1004. PubMed ID: 7573298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview].
    Genazzani AR; Cappagli B; Ciaponi M
    Minerva Ginecol; 2003 Jun; 55(3):189-200. PubMed ID: 14581864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women.
    Uhler ML; Marks JW; Voigt BJ; Judd HL
    J Clin Endocrinol Metab; 1998 Feb; 83(2):410-4. PubMed ID: 9467549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women.
    Cassidenti DL; Vijod AG; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1953-60. PubMed ID: 2256508
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen therapy in Turner syndrome: does the type, dose and mode of delivery matter?
    Mauras N; Torres-Santiago L; Taboada M; Santen R
    Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():718-22. PubMed ID: 22946283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of hormone replacement therapy on glucose metabolism.
    Colacurci N; Zarcone R; Mollo A; Russo G; Passaro M; de Seta L; de Franciscis P
    Panminerva Med; 1998 Mar; 40(1):18-21. PubMed ID: 9573748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of oral administration of estrogen replacement therapy in surgical menopause].
    Bomba-Opoń DA; Niesłuchowska-Frydrych B; Szucka-May H; Kamiński P; Marianowski L
    Ginekol Pol; 2001 Dec; 72(12A):1377-82. PubMed ID: 11883282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
    Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL
    J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH; Speroff L; Ellman H; Dart C
    Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause.
    Notelovitz M
    MedGenMed; 2006 Mar; 8(1):85. PubMed ID: 16915215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacology of estrogens and progestogens: influence of different routes of administration.
    Kuhl H
    Climacteric; 2005 Aug; 8 Suppl 1():3-63. PubMed ID: 16112947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estradiol vaginal inserts (Imvexxy): effective in genitourinary syndrome of menopause without increasing systemic estrogen levels.
    Paton DM
    Drugs Today (Barc); 2018 Nov; 54(11):667-677. PubMed ID: 30539166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.